[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Gordin et al., 2014 - Google Patents

Subcutaneous vs intramuscular botulinum toxin: split-face randomized study

Gordin et al., 2014

View PDF
Document ID
18169510130862174856
Author
Gordin E
Luginbuhl A
Ortlip T
Heffelfinger R
Krein H
Publication year
Publication venue
JAMA facial plastic surgery

External Links

Snippet

Importance Much has been published regarding rejuvenation of the upper face with botulinum toxin A injection; however, the optimal target tissue layer has not been specifically examined. Objective To seek a difference between subcutaneous (SC) and intramuscular …
Continue reading at jamanetwork.com (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A61K38/4893—Botulinum neurotoxin (3.4.24.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
    • A61B5/414—Evaluating particular organs or parts of the immune or lymphatic systems
    • A61B5/415—Evaluating particular organs or parts of the immune or lymphatic systems the glands, e.g. tonsils, adenoids or thymus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radiowaves
    • A61B5/053—Measuring electrical impedance or conductance of a portion of the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/44—Detecting, measuring or recording for evaluating the integumentary system, e.g. skin, hair or nails
    • A61B5/441—Skin evaluation, e.g. for skin disorder diagnosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/01—Measuring temperature of body parts; Diagnostic temperature sensing, e.g. for malignant or inflammed tissue
    • A61B5/015—By temperature mapping of body part
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00

Similar Documents

Publication Publication Date Title
Gordin et al. Subcutaneous vs intramuscular botulinum toxin: split-face randomized study
Nestor et al. Key parameters for the use of abobotulinumtoxinA in aesthetics: onset and duration
Alrefai et al. Treatment of sialorrhea in children with cerebral palsy: a double-blind placebo controlled trial
Weinberg et al. Botulinum neurotoxin treatment of palmar and plantar hyperhidrosis
Lee et al. Efficacy of glycopyrrolate in primary hyperhidrosis patients
De La Torre Canales et al. Botulinum toxin type A and acupuncture for masticatory myofascial pain: A randomized clinical trial
Nicol et al. Botulinum toxin type a injections for cervical and shoulder girdle myofascial pain using an enriched protocol design
Nahai et al. Consensus panel's assessment and recommendations on the use of 3 botulinum toxin type A products in facial aesthetics
Li et al. Investigation of the efficacy and safety of topical vibration anesthesia to reduce pain from cosmetic botulinum toxin A injections in Chinese patients: a multicenter, randomized, self-controlled study
Samotus et al. Personalized botulinum toxin type A therapy for cervical dystonia based on kinematic guidance
Karaahmet et al. Comparing the effectiveness of ultrasound-guided versus blind steroid injection in the treatment of severe carpal tunnel syndrome
Goo et al. Clinical efficacy and safety of thread-embedding acupuncture for treatment of the sequelae of Bell's palsy: A protocol for a patient-assessor blinded, randomized, controlled, parallel clinical trial
Atwa et al. Evaluation of intradermal injection of botulinum toxin A for facial lifting
Ploypetch et al. A retrospective review of unintended effects after single-event multi-level chemoneurolysis with botulinum toxin-A and phenol in children with cerebral palsy
Jung et al. Clinical investigation of botulinum toxin (prabotulinumtoxin A) for bruxism related to masseter muscle hypertrophy: A prospective study
Sykianakis et al. Botulinum toxin type A treatment is associated with improved social and psychological behavior: A retrospective study
Andersen et al. Clonidine used as a perineural adjuvant to ropivacaine, does not prolong the duration of sensory block when controlling for systemic effects: A paired, blinded, randomized trial in healthy volunteers
Rha et al. Ultrasound-guided lateral approach for needle insertion into the subscapularis for treatment of spasticity
Paolucci et al. Efficacy of trigger points mesotherapy for the treatment of chronic neck pain: a short term retrospective study
Sadala et al. Vibration anesthesia during carboxytherapy for cellulite: a study protocol
Park et al. Clinical effectiveness of thread-embedding acupuncture in the treatment of Bell's palsy sequelae: A randomized, patient-assessor-blinded, controlled, clinical trial
Ezzo Treatment and managed care issues of atopic dermatitis
Selvi et al. Evaluation of vapocoolant spray effect on pain reduction during digital nerve block: A randomized clinical trial
Lim et al. Improving upper limb spasticity in patients with stroke by electroacupuncture therapy: a pre-and post-treatment study
Nofal et al. Intradermal botulinum toxin a injection versus topical 2% glycopyrrolate for the treatment of primary facial hyperhidrosis: a pilot study and review of literature